Description of service

Two different bacterial expression systems for recombinant protein production: E. coli and L. lactis. SSI will provide access to its E. coli and L. Lactis platforms and will discuss optimisations of the antigen sequence for the chosen platform, design of the expression cassette, and carry out test runs depending on the user's demands.

Timeline 

3-5 months

Contact 

Charlotte Green Jensen

CGJ@ssi.dk

0045 32683963

Services do NOT include

Access to expression system.

Possible Output

Initial cell clone and mg protein for testing.

Sample Requirements - input of users

DNA sequence and characteristics of protein.

Lead Scientist

Charlotte Green Jensen

Cost coverage opportunities

If you are interested in this service please contact the service provider directly.

This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement N° 730964.

Be the first to know about the upcoming application calls, follow European Vaccine Initiative on:

  • LinkedIn Social Icon
  • Twitter Social Icon
Subscribe to TRANSVAC´s Mailing list

© 2020 European Vaccine Initiative. Designed by European Vaccine Initiative